Silent Heart Attack Raises Cerebral Infarction Risk
|
By HospiMedica International staff writers Posted on 06 Jun 2019 |
A new study reveals that asymptomatic (silent) heart attacks are associated with double the risk of cardiac embolism and stroke of undetermined cause.
Researchers at Weill Cornell Medical College (New York, NY, USA), the Icelandic Heart Association (IHA; Kopavogur, Iceland), and other institutions conducted a cross-sectional study that included 925 community-dwelling Icelandic individuals (51.9% women, mean age 75.9 years) who underwent both brain magnetic resonance imaging (MRI) and late gadolinium enhanced cardiac MRI to determine whether unrecognized mitral infarction (MI) is associated with cerebral infarction. The main outcomes and measures were unrecognized MI, defined as cardiac MRI evidence of MI without a history of clinical evidence.
The results revealed that 23.9% of participants had cardiac MRI evidence of a heart attack. Of these, 67 experienced MI with symptoms, while 153 had silent heart attack. Overall, 33% had brain MRI evidence of a stroke, and 10% had a stroke of undetermined cause. The researchers calculated that people with symptomatic MI were twice as likely to have a stroke, while those with silent heart attack were 1.5 times as likely to have a stroke. Adjusted for demographics and vascular risk factors, unrecognized MI was also associated with embolic infarcts of undetermined source. The study was published on May 20, 2019, in JAMA Neurology.
“Silent heart attack may be a risk factor for stroke, and may explain some proportion of stroke of undetermined cause; the clot formation that occurs with symptomatic heart attack may also occur with silent heart attack,” said lead study author neurologist Alexander Merkler, MD, of Weill Cornell Medical College. “If further studies confirm these results, doctors may more readily use cardiac MRI in patients with stroke of undetermined cause to see whether there is evidence of silent heart attack. They may also want to compare the effectiveness of anticoagulants to antiplatelet medications such as aspirin, which prevent platelets from clumping together.”
More than 700,000 people a year in the United States alone are diagnosed with a stroke, but in 20-25% of these patients, the cause of stroke cannot be determined. One possible explanation for these strokes is that a distant blood clot travels to the brain following a heart attack. About 50% of all heart attack patients do not experience any symptoms.
Related Links:
Weill Cornell Medical College
Icelandic Heart Association
Researchers at Weill Cornell Medical College (New York, NY, USA), the Icelandic Heart Association (IHA; Kopavogur, Iceland), and other institutions conducted a cross-sectional study that included 925 community-dwelling Icelandic individuals (51.9% women, mean age 75.9 years) who underwent both brain magnetic resonance imaging (MRI) and late gadolinium enhanced cardiac MRI to determine whether unrecognized mitral infarction (MI) is associated with cerebral infarction. The main outcomes and measures were unrecognized MI, defined as cardiac MRI evidence of MI without a history of clinical evidence.
The results revealed that 23.9% of participants had cardiac MRI evidence of a heart attack. Of these, 67 experienced MI with symptoms, while 153 had silent heart attack. Overall, 33% had brain MRI evidence of a stroke, and 10% had a stroke of undetermined cause. The researchers calculated that people with symptomatic MI were twice as likely to have a stroke, while those with silent heart attack were 1.5 times as likely to have a stroke. Adjusted for demographics and vascular risk factors, unrecognized MI was also associated with embolic infarcts of undetermined source. The study was published on May 20, 2019, in JAMA Neurology.
“Silent heart attack may be a risk factor for stroke, and may explain some proportion of stroke of undetermined cause; the clot formation that occurs with symptomatic heart attack may also occur with silent heart attack,” said lead study author neurologist Alexander Merkler, MD, of Weill Cornell Medical College. “If further studies confirm these results, doctors may more readily use cardiac MRI in patients with stroke of undetermined cause to see whether there is evidence of silent heart attack. They may also want to compare the effectiveness of anticoagulants to antiplatelet medications such as aspirin, which prevent platelets from clumping together.”
More than 700,000 people a year in the United States alone are diagnosed with a stroke, but in 20-25% of these patients, the cause of stroke cannot be determined. One possible explanation for these strokes is that a distant blood clot travels to the brain following a heart attack. About 50% of all heart attack patients do not experience any symptoms.
Related Links:
Weill Cornell Medical College
Icelandic Heart Association
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







